Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Bionano Genomics Reports Preliminary Q1 Revenues of $1.1M

Bionano Genomics Reports Preliminary Q1 Revenues of $1.1M

May 15, 2020
|
staff reporter

NEW YORK – Bionano Genomics announced Thursday preliminary first quarter revenues of $1.1 million, down sharply from revenues of $1.9 million in the first quarter of 2019.

The San Diego-based genome mapping company also said in a statement it is "suspending any guidance, anticipated timelines or other outlooks previously provided for 2020," due to uncertainty created by the COVID-19 pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep It (Partly) Virtual

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

For Cross-Protection

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Proteomics of Severity

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

Genome Biology Papers on Regulatory Element, Single-Cell Integration, Sequence Simulation Tools

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.

What's Popular?

In Business News

  1. Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

  2. Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

  3. Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

  4. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

  5. Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.